{"id":"NCT00809809","sponsor":"Integrative Medicine Institute","briefTitle":"Zinc for the Treatment of Herpes Simplex Labialis (HSL)","officialTitle":"A Randomized, Double-blind, Placebo-controlled, Multi-Center Trial of Zinc for the Treatment of Herpes Simplex Labialis (HSL)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-12","primaryCompletion":"2009-09","completion":"2010-12","firstPosted":"2008-12-17","resultsPosted":"2014-01-08","lastUpdate":"2014-01-08"},"enrollment":157,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Herpes Simplex Labialis"],"interventions":[{"type":"DRUG","name":"Zicam (Ionic zinc)","otherNames":["Homeopathic Zinc gluconate"]},{"type":"DRUG","name":"placebo","otherNames":["placebo swab"]}],"arms":[{"label":"Zinc gluconate","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Evaluate the effectiveness of a topical preparation of zinc to treat cold sores.","primaryOutcome":{"measure":"Zicam Was Compared to Placebo as a Treatment of Recurrent HSL From the Date and Time of the Initiation of Therapy Until the Date and Time of Resolution of the Lesion or After 14 Days of Treatment, Whichever Comes First.","timeFrame":"14 days","effectByArm":[{"arm":"Active Treatment","deltaMin":8,"sd":null},{"arm":"Placebo Treatment","deltaMin":6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":9},"locations":{"siteCount":3,"countries":["United States"]},"refs":{"pmids":["11347285"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":78},"commonTop":[]}}